Doxorubicin‐induced apoptosis in human T‐cell leukemia is mediated by caspase‐3 activation in a Fas‐independent way
Open Access
- 17 November 1997
- journal article
- Published by Wiley in FEBS Letters
- Vol. 417 (3), 360-364
- https://doi.org/10.1016/s0014-5793(97)01282-9
Abstract
It has recently been proposed that doxorubicin (DOX) can induce apoptosis in human T‐leukemia cells via the Fas/FasL system in an autocrine/paracrine way. We show here that treatment of Jurkat cells ...Keywords
This publication has 26 references indexed in Scilit:
- Release of preformed Fas ligand in soluble form is the major factor for activation‐induced death of Jurkat T cellsImmunology, 1996
- In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.Proceedings of the National Academy of Sciences, 1996
- CPP32 inhibition prevents Fas‐induced ceramide generation and apoptosis in human cellsFEBS Letters, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell DeathCell, 1996
- Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cellsNature Medicine, 1996
- ICE Family Proteases: Mediators of All Apoptotic Cell Death?Immunity, 1996
- FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosisCell, 1995
- T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin AEuropean Journal of Immunology, 1994
- Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.The Journal of Experimental Medicine, 1993